ArcDia International Oy Ltd is an ISO 13485 certified company for R&D, production and marketing of innovative products for point-of-care testing of infectious diseases, with special emphasis on respiratory tract infections.

ArcDia’s mariPOC® platform applies an automated random-access immunoanalyser for in vitro diagnostic use of its test kits. The platform is based on ArcDia’s proprietary two-photon excitation of fluorescence technology. The analysers are designed for multianalyte near-patient testing. They are bench-top in size, highly sensitive, and easy-to-use. The company is based in Turku, Finland.




People involved

Janne O. Koskinen PhD.